At a glance
ClinicalIndex Comparison RecordN/ACompleted· 192 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effect of Prevalence of Overweight and Obesity(Body Mass Index (BMI)) on Efficacy of Herbal Medicines(ZiYinXieHuo) in Girls' Sexual Precocity
In Brief
An observational study for Precocious Puberty. Completed, enrolled 192 participants across 1 site.
Detailed Summary
Effect of Prevalence of Overweight and Obesity(Body Mass Index (BMI)) on Efficacy of herbal medicines(ZiYinXieHuo) in girls sexual Precocity
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPrecocious Puberty
CountriesChina
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedDec 2020
Enrollment StartDec 2020
Primary CompletionNov 2022
Study CompletionJul 2023
TodayJul 2026
First PostedDec 14, 2020
Enrollment StartDec 18, 2020
Primary CompletionNov 30, 2022
Study CompletionJul 4, 2023
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 5.5 years ago